MICROBIOME AND EPIGENETIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPY IN PATIENTS WITH ULCERATIVE COLITIS

被引：0
|
作者：
Shah, Rajesh
Shen, Lanlan
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P166
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [31] Endoscopic and histological activity is associated with non-response to biologic therapy in ulcerative colitis
    Wann, S.
    Norris, R.
    Williams, R.
    Basnayake, C.
    Lust, M.
    Wright, E.
    Kamm, M.
    Connell, W.
    Thompson, A.
    Ding, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S376 - S376
  • [32] Predictors of response to faecal microbiota transplantation in patients with active ulcerative colitis
    Singh, A.
    Sood, A.
    Midha, V.
    Mahajan, R.
    Bansal, N.
    Kaur, K.
    Singh, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S339 - S341
  • [33] Predictors of non-response to repeated faecal microbiota transplantation in patients with therapy refractory ulcerative colitis
    Blesl, A.
    Rainer, F.
    Wurm, P.
    Durdevic, M.
    Petritsch, W.
    Wenzl, H.
    Baumann-Durchschein, F.
    Posch, A.
    Streit, A.
    Gorkiewicz, G.
    Groechenig, H. -P.
    Kump, P.
    Hoegenauer, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S412 - S412
  • [34] Predictors of early clinical response to infliximab in 100 patients with ulcerative colitis
    Ferrante, M.
    Vemeire, S.
    Katsanos, K. H.
    Noman, M.
    Van Assche, C.
    De Hertogh, G.
    Hoffman, I.
    Geboes, K.
    Rutgeerts, P.
    ACTA CLINICA BELGICA, 2006, 61 (05): : 299 - 299
  • [35] Predictors of Response to Infliximab As Salvage Therapy for Severe Steroid Refractory Ulcerative Colitis
    Vaughn, Byron P.
    Pleet, Julie
    Cheifetz, Adam S.
    Moss, Alan C.
    GASTROENTEROLOGY, 2013, 144 (05) : S434 - S434
  • [36] Female Crohn's disease patients and ulcerative colitis patients on biologic therapy are most disabled
    Spizzo, P.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S363 - S363
  • [37] Need and predictors of colectomy for Ulcerative Colitis patients in the biologic therapy era. A real life experience in a tertiary referral center
    Viazis, N.
    Anastasiou, J.
    Giakoumis, M.
    Chanias, M.
    Tzannetakou, X.
    Internos, I.
    Tsigaridas, A.
    Anastasopoulos, E.
    Karamanolis, D.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S307 - S307
  • [38] The role of the microbiome in clinical response to golimumab in ulcerative colitis
    Monast, C.
    Telesco, S.
    Li, K.
    Hayden, K.
    Brodmerkel, C.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S87 - S88
  • [39] Univariate Analysis to Examine Predictors of Response to Leukocytapheresis in Ulcerative Colitis Patients
    Nagayama, Koji
    Takedatsu, Hidetoshi
    Mitsuyama, Keiichi
    Yamasaki, Hiroshi
    Kuwaki, Kotaro
    Yoshioka, Shinichiro
    Kobayashi, Teppei
    Yamauchi, Ryosuke
    Kakuma, Tatsuyuki
    Sata, Michio
    THERAPEUTIC APHERESIS AND DIALYSIS, 2014, 18 (03) : 244 - 251
  • [40] Ciclosporin in severe ulcerative colitis: Predictors of response
    Cullen, Garret
    Keegan, Denise
    Mulcahy, Hugh E.
    O'Donoghue, Diarmuid P.
    GASTROENTEROLOGY, 2006, 130 (04) : A659 - A659
12345